Drug Shortage Report for SANDOZ FENOFIBRATE S
Report ID | 67590 |
Drug Identification Number | 02288052 |
Brand name | SANDOZ FENOFIBRATE S |
Common or Proper name | FENOFIBRATE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | FENOFIBRATE |
Strength(s) | 160MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 90 |
ATC code | C10AB |
ATC description | LIPID MODIFYING AGENTS, PLAIN |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2018-12-07 |
Actual start date | |
Estimated end date | 2019-01-28 |
Actual end date | 2018-12-11 |
Shortage status | Resolved |
Updated date | 2018-12-13 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2018-12-13 | French | Compare |
v4 | 2018-12-13 | English | Compare |
v3 | 2018-12-08 | English | Compare |
v2 | 2018-11-26 | French | Compare |
v1 | 2018-11-26 | English | Compare |
Showing 1 to 5 of 5